Subclinical inflammation in newly detected type II diabetes and impaired glucose tolerance [3]

Diabetologia

Volumn 45, Issue 1, 2002, Pages 151-

  Temelkova Kurktschiev, T ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; GLUCOSE; HEMOGLOBIN A1C;

ATHEROSCLEROSIS; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN RESISTANCE; LETTER; LEUKOCYTE COUNT; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; REFERENCE VALUES;

EID: 18244366670     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s125-002-8256-1     Document Type: Letter

References (9)

1. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the multiple risk factor intervention trial
2. 2 as an independent predictor of coronary heart disease
3. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
4. Chronic subclinical inflammation as a part of the insulin resistance syndrome (IRAS)
5. Increased intimal-medial thickness in newly detected type 2 diabetes. Risk factors
6. Relationship between fasting plasma glucose, atherosclerosis risk factors and carotid intima media thickness in nondiabetic individuals
7. Report of the expert committee on the diagnosis and classification of diabetes mellitus
8. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation
9. NIDDM as a disease of the innate immune system: Association of acute-phase reactants and interleukin-6 with metabolic syndrome X